CXApp receives Nasdaq bid price deficiency notice; must cure by March 2026

CXApp Inc.

Nasdaq notified CXApp on Sept 11, 2025 that common stock bid price below $1.00 for 30 consecutive business days.
Company has 180 days, until March 10, 2026, to regain compliance via $1.00 minimum closing bid for 10 days.
If not cured, may be eligible for an additional 180-day period; failure could lead to delisting.
No immediate effect on listing; common stock and warrants continue trading on Nasdaq Capital Market.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.